Mode
Text Size
Log in / Sign up
N/A N=117

Patient Preferences for Leadless Pacemakers

Cardiac Rhythm Disorder · Bradycardia · Cardiac Pacemaker Artificial

Enrolled (actual)
117
Serious AEs
Results posted
Feb 2025
Primary outcome: Primary: Mean Rankings for Pacemaker Device Features — 2.3; 2.6; 2.2; 4.7 score on a scale

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Patient Preference Survey (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Abbott Medical Devices
Primary completion
Jun 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Rankings for Pacemaker Device Features
2.3; 2.6; 2.2; 4.7; 5.1; 4.1
PRIMARY
Results From RPL Model of Discrete Choice Experiment Choice Questions - Preference Weights (Effect-coded Parameters)
0.340; -0.310; -0.030; 0.454; 0.253; -0.235
PRIMARY
Results From RPL Model of Discrete Choice Experiment Choice Questions- Standard Deviations
0.490; 1.411; 0.921; 0.562; 0.420; 0.242
PRIMARY
Maximum-acceptable Risks of a Complication
13.4; 0; 0; 7.6; 0; 14.5
PRIMARY
Maximum-acceptable Risks of an Infection
16.8; 0; 0; 8.9; 0; 17.8
PRIMARY
Probability of Choosing Specified Pacemakers - All 3 Profiles
41.7; 8.0; 27.4; 4.5; 30.9; 87.5
PRIMARY
Probability of Choosing Specified Pacemakers - Leadless Pacemaker Removable vs. Leadless Pacemaker Non-removable
60.4; 64.0; 39.6; 36
PRIMARY
Probability of Choosing Specified Pacemakers - Leadless Pacemaker Removable vs. Pacemaker With Leads
57.4; 8.4; 42.6; 91.6
PRIMARY
Probability of Choosing Specified Pacemakers - Leadless Pacemaker Non-removable vs. Pacemaker With Leads
46.9; 4.9; 53.1; 95.1
SECONDARY
Constrained 2-class Latent-class Model Preference Weights
50.5; 49.6
SECONDARY
Number of Discrete Choice Experiment Questions Answered
41; 76
SECONDARY
Association of Patient Characteristics With Membership in the Transvenous Class Versus the Leadless Class
1.15; 0.99; 1.05; 1.55; 2.73; 0.98

Summary

Prospective, non-randomized, multi-center study designed to quantify patient preferences pertaining to risks and features of conventional transvenous pacemakers and leadless pacemakers

Eligibility Criteria

Inclusion Criteria

  • Able to read and speak English to consent to participate in the survey
  • Willing and able to use a tablet or computer to complete the survey
  • Scheduled to undergo evaluation for a de novo cardiac pacemaker at the study site (patient may or may not have a known indication for a pacemaker at the time)

Exclusion Criteria

  • None
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05327101). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search